Department of Health and Social Care (DHSC) has issued a medicine supply notification for Pancrease® HL gastro-resistant capsules.

MSN/2023/095

Tier 2 – medium impact

Date of issue 12th October 2023

Pancrease® HL gastro-resistant capsules are being discontinued with stock expected to be exhausted by mid-November 2023.
Alternative high strength pancreatin preparations remain available and will be able to support increased demand.

A copy of this medicine supply notification, including further information for pharmacy teams, has been sent to all pharmacy NHS email addresses.

DHSC and NHSE/I have now launched an online Medicines Supply Tool, which provides up to date information about medicine supply issues. The contents of these MSNs can now be viewed on the Tool.

The Tool also details any changes to resupply dates and updates to the entries.

To access the Tool you will need  an NHS email address. Once set up and logged in, you will be able to access it online.

New shortages not listed on the SPS website, can be reported using our shortage reporting tool.

The post Medicine Supply Notification: Pancrease® HL gastro-resistant capsules appeared first on Community Pharmacy England.